Patents by Inventor Michele M. Cudahy

Michele M. Cudahy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6878705
    Abstract: The invention provides a compound of formula I: wherein G, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: April 12, 2005
    Assignee: Pfizer
    Inventors: Michele M. Cudahy, Mark E. Schnute, Steven P. Tanis, William R. Perrault, Paul Matthew Herrinton, Sajiv K. Nair
  • Publication number: 20040259907
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: January 14, 2003
    Publication date: December 23, 2004
    Inventors: Michele M. Cudahy, Mark E. Schnute, Steven P. Tanis, William R. Perrault, Paul Matthew Herrinton, Sajiv K. Nair
  • Publication number: 20040116464
    Abstract: The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Application
    Filed: August 27, 2003
    Publication date: June 17, 2004
    Inventors: Mark E. Schnute, Michele M. Cudahy, Fred L. Ciske, Michael J. Genin, David John Anderson, Thomas M. Judge, MariJean Eggen, Sarah A. Collier
  • Publication number: 20040110787
    Abstract: The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Application
    Filed: August 27, 2003
    Publication date: June 10, 2004
    Inventors: Mark E. Schnute, Michele M. Cudahy, David John Anderson, Thomas M. Judge, Thomas J. Fleck, Paul Matthew Herrinton, Sajiv K. Nair, Allen Scott, William R. Perrault, Steve P. Tanis, James A. Nieman, Sarah A. Collier, Bruce F. Fleck
  • Publication number: 20020006937
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: April 2, 2001
    Publication date: January 17, 2002
    Applicant: PHARMACIA & UPJOHN COMPANY
    Inventors: Mark E. Schnute, Michele M. Cudahy, Allen Scott
  • Patent number: 6239142
    Abstract: The invention provides a compound of formula I: wherein R1, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of preventing or treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: May 29, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Mark E. Schnute, Michele M. Cudahy, Allen Scott
  • Patent number: 6093732
    Abstract: The present invention provides 4-hydroxyquinoline-3-carboxamide and hydrazide compounds of formula I ##STR1## These compounds are useful to treat or prevent the herpesviral infections, particularly, human cytomegaloviral infection.
    Type: Grant
    Filed: December 1, 1998
    Date of Patent: July 25, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: John Alan Tucker, Valerie A. Vaillancourt, Joseph Walter Strohbach, Karen Rene Romines, Mark E. Schnute, Michele M. Cudahy, Suvit Thaisrivongs, Steven Ronald Turner